Page results
-
This patient information aims to address the questions you may have about surgical management of endometriosis.
-
This information will help you understand your forthcoming treatment and contains answers to many frequently asked questions.
-
Information about incentive spirometry (IS) for adults with sickle cell disorder.
-
The pelvic pain management service at UCLH was established in 2006 and our clinicians have a wealth of experience in managing women with abdominal and pelvic pain, and especially with those who have experienced complications following mesh implantation.
-
The Oesophageal and stomach surgery service works very closely with the specialist Upper Gastrointestinal (GI) service, gastroenterology, nutrition, oncology and radiology departments at UCLH. It comprises UCLH-based and Barts Health-based surgeons.
-
UCLH provides an audiological service for GPs who would like to refer patients for age related audiological assessments.
-
This information is for children and young people with type 1 diabetes using a hybrid closed loop (HCL).
-
We are making it easier and safer for patients to be seen in an Emergency Department (ED) or Accident and Emergency (A&E) department without waiting for long periods of time.
-
Information about community sickle cell and thalassaemia services provided via UCLH.
-
This information page aims to answer some of the questions you may have about receiving chimeric antigen receptor (CAR) T-cell therapy at University College London Hospitals NHS Foundation Trust (UCLH).
File results
-
FOI/2022/0193 - Drug treatment for breast cancer
-
FOI/2022/0194 - Drug treatment for lung cancer
-
FOI/2022/0199 - Trust postal service and patient communication
-
FOI/2022/0200 - IT budget/ chatbots
-
FOI/2022/0205 - Spending on communication activities
-
FOI/2022/206 - Rates for Bonham Carter House 52-54 Gower Street
-
FOI/2022/0207 - Patient treatment with Nivolumab
-
FOI/2022/0209 - Patient tracking list or waiting lists
-
FOI/2022/0211 - Enteral feeding machine mechanical insufflator
-
FOI/2022/0212 - Clotting disorders medication